
Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 9.15
0.0%
Quarterly report 2022-Q2
added 12-16-2023
Biohaven Pharmaceutical Holding Company Ltd. Total Inventories 2011-2026 | BHVN
Annual Total Inventories Biohaven Pharmaceutical Holding Company Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 80.6 M | 39.6 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 80.6 M | 39.6 M | 60.1 M |
Quarterly Total Inventories Biohaven Pharmaceutical Holding Company Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 107 M | 91.3 M | 80.6 M | 74.9 M | 64.1 M | 58.3 M | 39.6 M | 20.1 M | 8.97 M | 4.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 107 M | 4.58 M | 54.9 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.66 | - | $ 16.7 M | ||
|
Cerus Corporation
CERS
|
56.1 M | $ 1.85 | - | $ 353 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.67 | - | $ 196 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
440 K | $ 0.44 | - | $ 5.04 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
37.2 M | $ 24.98 | - | $ 3.05 B | ||
|
Crinetics Pharmaceuticals
CRNX
|
2.02 M | $ 37.7 | - | $ 3.55 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 330.34 | - | $ 43.3 B |